MLEC Stock Analysis: Buy, Sell, or Hold?
MLEC - Moolec Science SA Ordinary Shares
$4.75
-0.06 (-1.25%)
βΌ
5d:
-15.18%
30d:
-30.25%
90d:
-40.36%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Apr 15, 2026
0d
Get Alerted When MLEC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
βΈοΈ WAIT FOR STABILIZATION: MLEC is down 15.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
βΈοΈ WAIT FOR STABILIZATION: MLEC is down 15.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: MLEC is currently trading at $4.75, which is considered oversold relative to its 30-day fair value range of $5.42 to $7.07.
Technical Outlook: Technically, MLEC is in a downtrend. Immediate support is located at $4.59, while resistance sits at $6.36.
Market Sentiment: MLEC scores 68/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. However, the stock is trading significantly above the average Wall Street target of $3.00. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MLEC is in a downtrend. Immediate support is located at $4.59, while resistance sits at $6.36.
Market Sentiment: MLEC scores 68/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. However, the stock is trading significantly above the average Wall Street target of $3.00. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$5.42 -
$7.07
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
84.2%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (68/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 36.8% above Wall St target ($3.00)
- WARNING: Composite score 51/100 in the bottom quintile β this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$5.42 -
$7.07
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$4.59
Resistance Level
$6.36
Current Trend
Downtrend
Technical data as of
Oct 2, 2026
Fundamental Context
Wall Street Target
$3.00
(-36.8%)
Revenue Growth (YoY)
948.3%
Share & Embed Analysis
Last updated: October 03, 2026 3:02 PM ET
Data refreshes hourly during market hours. Next update: 4:02 PM
Data refreshes hourly during market hours. Next update: 4:02 PM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MLEC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 49 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1180 | 52 HOLD |
|
LEGN
Legend BiotechΒ Corp |
STRONG BUY
22 analysts |
$47 | 46 HOLD |
|
REGN
Regeneron Pharmaceutical⦠|
STRONG BUY
25 analysts |
$851 | 48 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$293 | 67 BUY |